Rugby

Timed Release Niacin 750 mg

D
N+ Score62
Vitamins & MineralsServing: 1 Tablet(s)Type: Vitamin

Rugby Timed Release Niacin 750 mg is a single-ingredient vitamin supplement providing a substantial dose of Niacin. Each tablet delivers 750 mg of Niacin, which research suggests is a clinically studied dosage for certain applications. The product achieves an N+ Score of 62, earning a 'D' grade, indicating an average rating within our evaluation framework. While it offers 100% label transparency and the ingredient is adequately dosed, its formula completeness is low due to being a single-ingredient product. This supplement may be suitable for individuals specifically advised to supplement with high-dose niacin.

About This Product

Timed Release Niacin 750 mg by Rugby is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 62/100 (Grade D).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Niacin.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category
  • Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Niacin750.000 mgHigh

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.